Pharco Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Pharco Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4 (NCT02371408) | Pharco Pharmaceuticals | 2015-01-01 |
| Safety and Efficacy of Mirazid for Schistosomiasis Treatment (NCT01529710) | Pharco Pharmaceuticals | 2011-12-01 |
Track Pharco Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.